Affiliation:
1. Tehran University of Medical Sciences
Abstract
Abstract
Background: Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a rare multisystem mitochondrial cytopathy that is highly heterogeneous in severity and clinical presentation mostly caused by diverse mutations in the mitochondrial DNA. Clinical spectrum of MELAS is broadening as atypical presentations and more knowledge are gathering from this syndrome. There is no specific known treatment for the progressive disease however metabolic cocktail have been used to improve ATP production.
Case presentation: This report documents the case of a 37 year old Iranian woman diagnosed with MELAS. Her clinical manifestations include recurrent episodes of stroke-like events, focal seizures and elevated serum and CSF lactate. Mitochondrial DNA analysis (mtDNA) was positive for a very rare pathogen point mutation (mtDNA; m.3243A>G) in the MT-ND5 gene with a heteroplasmy level of 8.2%.
Conclusion: The clinical spectrum of MELAS is broadening as its atypical presentations make a diagnostic challenge that may lead to decades of delay in diagnosis. The number of molecular causes of MELAS and Leigh syndrome (LS) has increased steadily.
Publisher
Research Square Platform LLC
Reference12 articles.
1. Fan HC et al. Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes.Life (Basel), 2021. 11(11).
2. When should MELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) be the diagnosis?;Lorenzoni PJ;Arq Neuropsiquiatr,2015
3. Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with suspected recurrent strokes - a case report;Sinnecker T;BMC Neurol,2019
4. Truth is a daughter of time: a case of MELAS diagnosed 25 years after initial manifestation;Windpessl M;Oxf Med Case Rep,2014
5. Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A > G MTTL1 mutation;Tschampa HJ;J Neurol,2013